Showing results (111-120 of 205) with videos related to
Sort By:
Pageof 21
Agents and Actions|January 1, 1993
Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected roleC Agen, R Danesi, C Blandizzi, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 3, 2009
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatmentR Colucci, M Fornai, L Antonioli, et al.British Journal of Cancer|July 30, 2005
Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cellsG Bocci, A Fioravanti, P Orlandi, et al.Neuroscience Letters|May 24, 1996
Determination on functional basis of presynaptic alpha 2-adrenoceptor subtypes in guinea-pig duodenumR Colucci, C Blandizzi, D Carignani, et al.British Journal of Cancer|February 9, 2005
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profileE Giovannetti, V Mey, R Danesi, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 27, 2007
Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a reviewR Colucci, M Fornai, M Tuccori, et al.European Journal of Pharmacology|July 17, 1999
CCK1 and CCK2 receptors regulate gastric pepsinogen secretionC Blandizzi, G Lazzeri, R Colucci, et al.Toxicology and Applied Pharmacology|July 5, 2001
Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damageG Natale, G Lazzeri, C Blandizzi, et al.European Journal of Pharmacology|December 27, 1995
Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized ratsC Blandizzi, R Colucci, D Carignani, et al.Toxicology and Applied Pharmacology|December 13, 2001
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: a preclinical studyC Blandizzi, B De Paolis, R Colucci, et al.Pageof 21